Associate Professor of Urology.
University of Washington, United States
Dr. Sarah Psutka MD, MSc is an Associate Professor of Urology in the Department of Urology at the University of Washington and Fred Hutchinson Cancer Center. She received her undergraduate and medical degrees from Harvard University and completed urology residency training at the Massachusetts General Hospital followed by a Society of Urologic Oncology Fellowship at the Mayo Clinic, and concurrently obtained her Masters in Clinical and Translational Science. At UW, she specializes in bladder, kidney, and testis cancer care, leads the urologic oncology program at Harborview Medical Center and is the Program Director of the UW SUO Fellowship in Urologic Oncology.
Dr. Psutka’s leads research integrating principles of aging research, comprehensive geriatric assessments, body composition, and resilience in patients with advanced GU malignancies with a focus on patient-centric outcomes. She is a clinical trialist, currently leading the UW GetMoving and the UW EMPOWER Randomized Controlled Trials which evaluate personalized home-based prehabilitation exercise intervention delivered via digital applications perioperatively and in survivorship settings. Her research has been funded by the National Institute on Aging (2022-2024 GEMSSTAR award), the Bladder Cancer Advocacy Network, and the Andy Hill Care Foundation. She was the 2022 Recipient of the Society of Urologic Oncology Young Investigator Award and the 2023 Kidney Cancer Association Christopher G. Wood Rising Star Award. She serves on the SUO Clinical Trials Consortium Board of Directors (Kidney), AUA Practice Guidelines Committee, and is the Cancer Control Committee Liaison for the SWOG Genitourinary Executive Committee. She co-founded the Society of Women in Urologic Oncology in 2019. Dr. Psutka served as the Senior Editor for the Oncology Section of the AUA Core Curriculum from 2019-2023 and is currently the Senior Consultant for Oncology and the Chair Elect for the AUA Core Curriculum 2026. She is an Associate Editor for European Urology.
B2B-06: Redefining Treatment for High-Risk NMIBC Through Innovative Technologies
Saturday, November 1, 2025
08:15 - 08:25 GMT+0
B2B-06: Panel Discussion and Q&A
Saturday, November 1, 2025
08:35 - 08:45 GMT+0
Saturday, November 1, 2025
14:00 - 15:30 GMT+0
Saturday, November 1, 2025
14:00 - 14:05 GMT+0